BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20014453)

  • 1. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I; Lugli A
    World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
    Zlobec I; Lugli A
    Oncotarget; 2010 Nov; 1(7):651-61. PubMed ID: 21317460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
    Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
    Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
    Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.
    Lugli A; Karamitopoulou E; Panayiotides I; Karakitsos P; Rallis G; Peros G; Iezzi G; Spagnoli G; Bihl M; Terracciano L; Zlobec I
    Br J Cancer; 2009 Oct; 101(8):1382-92. PubMed ID: 19755986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
    Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
    Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma.
    Umemura K; Takagi S; Shimada T; Masuda T; Shiga H; Takahashi S; Takahashi S; Kinouchi Y; Shibuya D; Shimosegawa T
    Tohoku J Exp Med; 2013 Jan; 229(1):53-9. PubMed ID: 23238650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
    Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
    Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue.
    Markowski AR; Markowska AJ; Ustymowicz W; Pryczynicz A; Guzińska-Ustymowicz K
    Sci Rep; 2022 Dec; 12(1):21732. PubMed ID: 36526699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
    Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
    Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding: a promising parameter in colorectal cancer.
    Lugli A; Karamitopoulou E; Zlobec I
    Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?
    Jiang B; Mason J; Jewett A; Qian J; Ding Y; Cho WC; Zhang X; Man YG
    Int J Biol Sci; 2013; 9(1):119-33. PubMed ID: 23355797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?
    Jiang B; Mason J; Jewett A; Liu ML; Chen W; Qian J; Ding Y; Ding S; Ni M; Zhang X; Man YG
    Int J Med Sci; 2013; 10(5):475-97. PubMed ID: 23532368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
    Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
    Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment.
    Hacking S; Sajjan S; Angert M; Ebare K; Jin C; Chavarria H; Kataria N; Zhang L; Cho M; Thomas R; Lee L; Nasim M
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):627-634. PubMed ID: 31567276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
    Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
    Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
    Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
    BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.